Double-blind study of oral gamma-vinyl GABA in the treatment of dystonia
- PMID: 3941792
- DOI: 10.1212/wnl.36.1.98
Double-blind study of oral gamma-vinyl GABA in the treatment of dystonia
Abstract
Six patients with different forms of dystonia were treated with gamma-vinyl GABA, a specific enzyme-activated inhibitor of GABA-transaminase, in a double-blind, placebo-controlled crossover study. gamma-Vinyl GABA therapy, 2 g daily for 2 weeks, was compared with placebo by weekly assessments. There were no consistent changes in three evaluation scores. Agents that augment CNS GABA are unlikely to benefit patients with generalized dystonia.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical